Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Infanrix/Hib vs Separate Infanrix and Hiberix in Chinese Infants
NCT00412854Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2007
- Primary completion
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Infanrix Hib in diphtheria, Tetanus, pertussis, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jan 2007; status: completed.
02
Drugs
Infanrix Hib
03
Conditions
diphtheriaTetanuspertussisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00412854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412854.